Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Nephros (NEPH) Shares Outstanding (Diluted Average) (2022 - 2025)

Nephros (NEPH) has 9 years of Shares Outstanding (Diluted Average) data on record, last reported at $11.0 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Diluted Average) rose 4.35% year-over-year to $11.0 million; the TTM value through Sep 2025 reached $11.0 million, up 4.35%, while the annual FY2024 figure was $10.6 million, 2.08% up from the prior year.
  • Shares Outstanding (Diluted Average) reached $11.0 million in Q3 2025 per NEPH's latest filing, up from $10.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $11.0 million in Q3 2025 and bottomed at $10.3 million in Q4 2022.
  • Average Shares Outstanding (Diluted Average) over 4 years is $10.5 million, with a median of $10.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Diluted Average): dropped 0.02% in 2023, then rose 4.35% in 2025.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $10.3 million in 2022, then grew by 0.86% to $10.4 million in 2023, then increased by 2.08% to $10.6 million in 2024, then increased by 4.14% to $11.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Diluted Average) were $11.0 million in Q3 2025, $10.7 million in Q2 2025, and $10.6 million in Q1 2025.